Zenas Technologies Will Head to Society of Toxicology Annual Meeting in March

New Orleans, Louisiana (January 2012) – Zenas Technologies will be exhibiting at the Society of Toxicology 51st Annual Meeting in San Francisco March 11-15.

“Zenas Technologies attended SOT last year and we found it an ideal venue for clearly communicating our cardiac and CNS ion channel services and assays,” says Brent Kovach, Zenas Business Development Director.

Zenas Technologies will also be unveiling several new assays adding to the company’s comprehensive cardiovascular and central nervous system capabilities.

“We welcome the opportunity to unveil our new offerings,” says Dr. William Crumb, Zenas Founder and Scientific Director. “I look forward to explaining how we leverage the scientific advantages of our comprehensive assays, from utilizing native human cardiac myocytes at physiologic temperatures to screening compounds against neuronal ion channels in our CNS screenings.”

Zenas Technologies will be meeting with clients and colleagues, as well as scheduling one-on-one appointments, to discuss their proprietary models, proven data packages and consulting services.


Our proven cardiac and CNS data packages, nuanced interpretations and consulting services help our clients make key decisions on leading drug candidates early in the development process—saving time, money and

To schedule time with the Zenas Technologies team, please contact
Brent Kovach at: bkovach@zenastech.com.

For more information about Zenas Technologies, please visit www.zenastech.com.

Dr. William Crumb, Founder/Scientific Director of Zenas Technologies

Brent Kovach, Director of Business Development

Back to News & Events